Gaush Meditech Ltd — Board/Management Information 2025

Aug 28, 2025

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

高视 GAUSH

Gaush Meditech Ltd

高视医疗科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2407)

CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE

The board (the "Board") of directors (the "Directors") of Gaush Meditech Ltd (the "Company") hereby announces that with effect from August 28, 2025, Mr. Gao Tieta ("Mr. Gao"), the chairman of the Board and an executive Director, has ceased to be a member of the nomination committee of the Company (the "Nomination Committee"), and Ms. Li Wenqi ("Ms. Li"), an executive Director, has been appointed as a member of the Nomination Committee in order to fulfil the new gender diversity requirement of the Nomination Committee under the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. Immediately following the change in composition of the Nomination Committee, the Nomination Committee consists of Mr. Wang Li-Shin (chairman), Mr. Feng Xin and Ms. Li.

The Board would like to take the opportunity to express its sincere gratitude to Mr. Gao for his valuable contribution to the Company during his tenure of service as a member of the Nomination Committee and extend a warm welcome to Ms. Li in joining the Nomination Committee.

By order of the Board

Gaush Meditech Ltd

Mr. Gao Tieta

Chairman and Executive Director

Hong Kong, August 28, 2025

As of the date of this announcement, the Board comprises Mr. Gao Tieta as Chairman and executive Director, Mr. Liu Xinwei, Mr. Zhao Xinli, Mr. Zhang Jianjun and Ms. Li Wenqi as executive Directors, Dr. David Guowei Wang as non-executive Director, and Mr. Feng Xin, Mr. Wang Li-Shin and Mr. Chan Fan Shing as independent non-executive Directors.